SCHEMBL1683808

SCHEMBL1683808

COc1cc(C(=NNI)C2COC(c3ccccc3)N2)cc(OC)c1OC

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACHE P22303 2/20 0.37
▸ PTPN1 P18031 1/20 0.37
▸ ALDH1A1 P00352 5/20 0.37
▸ KDM4E B2RXH2 4/20 0.37
▸ MEN1 O00255 2/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ CYP2D6 P10635 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ TAAR1 Q96RJ0 1/20 0.37
▸ TDP1 Q9NUW8 1/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ MAPK3 P27361 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ KDM1A O60341 1/20 0.35
▸ TUBB4A P04350 5/20 0.35
▸ TUBB P07437 5/20 0.35
▸ TUBA3C P0DPH7 5/20 0.35
▸ TUBA1B P68363 5/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1683931 0.88 ACHE (0.39) ACHEPTPN1ALDH1A1KDM4EMEN1
SCHEMBL1683785 0.88 ACHE (0.39) ACHEPTPN1ALDH1A1KDM4EMEN1
SCHEMBL1683779 0.88 ACHE (0.39) ACHEPTPN1ALDH1A1KDM4EMEN1
SCHEMBL1683848 0.87 ACHE (0.39) ACHEPTPN1ALDH1A1KDM4EMEN1
SCHEMBL4416053 0.87 ACHE (0.39) ACHEPTPN1ALDH1A1KDM4EMEN1
SCHEMBL1683845 0.87 ACHE (0.39) ACHEPTPN1ALDH1A1KDM4EMEN1
SCHEMBL1683770 0.81 ACHE (0.41) ACHEPTPN1ALDH1A1KDM4EMEN1
SCHEMBL1683813 0.81 ALDH1A1 (0.44) ACHEPTPN1ALDH1A1KDM4EMEN1
SCHEMBL1683619 0.76 ATM (0.46) ALDH1A1KDM4EMEN1KMT2ASMN1; SMN2
SCHEMBL4423902 0.75 ALDH1A1 (0.41) ACHEPTPN1ALDH1A1KDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2303021-A2 COMPOUNDS FOR THE TREATMENT OF CANCER University of Tennessee Research Foundation (US) 2011-04-06 — — EP disclosed
WO-2010074776-A2 COMPOUNDS FOR THE TREATMENT OF CANCER THE UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) 2010-07-01 — — WO disclosed
Send feedback